However, in the context of the role of (m)SOD‐1 and MCP‐2 in familial ALS, our findings suggest that assessing serum levels of MCP‐2 and/or TARC in the early stages of the disease may be informative for sporadic ALS disease prognoses. The gene discussed is CCL17; the disease is amyotrophic lateral sclerosis.